The prevalence of infection with the genital herpes simplex virus type 2 (HSV-2) has been difficult to ascertain, primarily because of the large percentage of subclinical cases and the limitations in specificity of serologic assays for antibody to HSV-2. To obtain an improved estimate of the distribution of HSV-2 infection in the United States, we used an HSV type-specific antibody assay to test serum samples from 4201 participants in the second National Health and Nutrition Examination Survey. The results in our sample indicate that in the period from 1976 to 1980, 16.4 percent of the U.S. population 15 to 74 years of age (approximately 25 million persons) was infected with HSV-2 (95 percent confidence interval, 14.2 to 18.6 percent). Age and race were the demographic factors associated most strongly with the presence of HSV-2 antibody. The prevalence of the antibody increased from less than 1 percent in the group under 15 years old to 20.2 percent in the group 30 to 44 years old; it increased only slightly thereafter. In the oldest group, 60 to 74 years of age, the prevalence was 19.7 percent in whites and 64.7 percent in blacks. Among blacks of all age groups, but not whites, higher rates were observed in women than in men. The associations were weaker with respect to marital status, income, education, urban residence, and region of the country. After control for age, sex, and race, only the association with marital status remained significant; the rate was increased in persons previously married--i.e., divorced, separated, or widowed. We conclude that the prevalence of HSV-2 infection in the United States is higher than has previously been recognized and that many infections with this sexually transmitted virus may be subclinical.
Source Information
Division of Sexually Transmitted Diseases, Centers for Disease Control, Atlanta, GA.
This article has been cited by other articles:
Mindel, A, McHugh, L, Christie, E, Chung, C, Berger, T
(2009). Genital herpes: an Internet-based risk survey. Int J STD AIDS
20: 785-789
[Abstract][Full Text]
Sloan, D. D., Jerome, K. R.
(2007). Herpes Simplex Virus Remodels T-Cell Receptor Signaling, Resulting in p38-Dependent Selective Synthesis of Interleukin-10. J. Virol.
81: 12504-12514
[Abstract][Full Text]
Cunningham, A L, Taylor, R, Taylor, J, Marks, C, Shaw, J, Mindel, A
(2006). Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey.. Sex. Transm. Infect.
82: 164-168
[Abstract][Full Text]
Sloan, D. D., Han, J.-Y., Sandifer, T. K., Stewart, M., Hinz, A. J., Yoon, M., Johnson, D. C., Spear, P. G., Jerome, K. R.
(2006). Inhibition of TCR Signaling by Herpes Simplex Virus. J. Immunol.
176: 1825-1833
[Abstract][Full Text]
Krantz, I., Lowhagen, G.-B., Ahlberg, B. M., Nilstun, T.
(2004). Ethics of screening for asymptomatic herpes virus type 2 infection. BMJ
329: 618-621
[Full Text]
Pebody, R G, Andrews, N, Brown, D, Gopal, R, de Melker, H, Francois, G, Gatcheva, N, Hellenbrand, W, Jokinen, S, Klavs, I, Kojouharova, M, Kortbeek, T, Kriz, B, Prosenc, K, Roubalova, K, Teocharov, P, Thierfelder, W, Valle, M, Van Damme, P, Vranckx, R
(2004). The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex. Transm. Infect.
80: 185-191
[Abstract][Full Text]
Song, B, Dwyer, D E, Mindel, A
(2004). HSV type specific serology in sexual health clinics: use, benefits, and who gets tested. Sex. Transm. Infect.
80: 113-117
[Abstract][Full Text]
Kimberlin, D. W.
(2004). Neonatal Herpes Simplex Infection. Clin. Microbiol. Rev.
17: 1-13
[Abstract][Full Text]
Fisman, D N, Hook, E W III, Goldie, S J
(2003). Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2. Sex. Transm. Infect.
79: 45-52
[Abstract][Full Text]
Malkin, J-E, Morand, P, Malvy, D, Ly, T D, Chanzy, B, de Labareyre, C, El Hasnaoui, A, Hercberg, S
(2002). Seroprevalence of HSV-1 and HSV-2 infection in the general French population. Sex. Transm. Infect.
78: 201-203
[Abstract][Full Text]
Tideman, R L, Taylor, J, Marks, C, Seifert, C, Berry, G, Trudinger, B, Cunningham, A, Mindel, A
(2001). Sexual and demographic risk factors for herpes simplex type 1 and 2 in women attending an antenatal clinic. Sex. Transm. Infect.
77: 413-415
[Abstract][Full Text]
Armstrong, G. L., Schillinger, J., Markowitz, L., Nahmias, A. J., Johnson, R. E., McQuillan, G. M., St. Louis, M. E.
(2001). Incidence of Herpes Simplex Virus Type 2 Infection in the United States. Am J Epidemiol
153: 912-920
[Abstract][Full Text]
van Benthem, B H B, Spaargaren, J, van den Hoek, J A R, Merks, J, Coutinho, R A, Prins, M
(2001). Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. Sex. Transm. Infect.
77: 120-124
[Abstract][Full Text]
Corey, L., Handsfield, H. H.
(2000). Genital Herpes and Public Health: Addressing a Global Problem. JAMA
283: 791-794
[Abstract][Full Text]
Eis-Hübinger, A. M., Däumer, M., Matz, B., Schneweis, K. E.
(1999). Evaluation of Three Glycoprotein G2-Based Enzyme Immunoassays for Detection of Antibodies to Herpes Simplex Virus Type 2 in Human Sera. J. Clin. Microbiol.
37: 1242-1246
[Abstract][Full Text]
Schmid, D. S., Brown, D. R., Nisenbaum, R., Burke, R. L., Alexander, D'A., Ashley, R., Pellett, P. E., Reeves, W. C.
(1999). Limits in Reliability of Glycoprotein G-Based Type-Specific Serologic Assays for Herpes Simplex Virus Types 1 and 2. J. Clin. Microbiol.
37: 376-379
[Abstract][Full Text]
Carr, D. J. J., Veress, L. A., Noisakran, S., Campbell, I. L.
(1998). Astrocyte-Targeted Expression of IFN-{alpha}1 Protects Mice from Acute Ocular Herpes Simplex Virus Type 1 Infection. J. Immunol.
161: 4859-4865
[Abstract][Full Text]
Tyring, S. K., Douglas, J. M. Jr, Corey, L., Spruance, S. L., Esmann, J., for the Valaciclovir International Study Group,
(1998). A Randomized, Placebo-Controlled Comparison of Oral Valacyclovir and Acyclovir in Immunocompetent Patients With Recurrent Genital Herpes Infections. Arch Dermatol
134: 185-191
[Abstract][Full Text]
Ashley, R., Wu, L, Pickering, J., Tu, M., Schnorenberg, L
(1998). Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies [In Process Citation]. J. Clin. Microbiol.
36: 294-295
[Abstract][Full Text]
Fleming, D. T., McQuillan, G. M., Johnson, R. E., Nahmias, A. J., Aral, S. O., Lee, F. K., St. Louis, M. E.
(1997). Herpes Simplex Virus Type 2 in the United States, 1976 to 1994. NEJM
337: 1105-1111
[Abstract][Full Text]
Brown, Z. A., Selke, S., Zeh, J., Kopelman, J., Maslow, A., Ashley, R. L., Watts, D. H., Berry, S., Herd, M., Corey, L.
(1997). The Acquisition of Herpes Simplex Virus during Pregnancy. NEJM
337: 509-516
[Abstract][Full Text]
Lauer, K.
(1997). Diet and multiple sclerosis. Neurology
49: S55-S61
[Full Text]
Spruance, S. L., Tyring, S. K., DeGregorio, B., Miller, C., Beutner, K.
(1996). A Large-Scale, Placebo-Controlled, Dose-Ranging Trial of Peroral Valaciclovir for Episodic Treatment of Recurrent Herpes Genitalis. Arch Intern Med
156: 1729-1735
[Abstract]
Sacks, S. L., Aoki, F. Y., Diaz-Mitoma, F., Sellors, J., Shafran, S. D.
(1996). Patient-Initiated, Twice-Daily Oral Famciclovir for Early Recurrent Genital Herpes: A Randomized, Double-blind Multicenter Trial. JAMA
276: 44-49
[Abstract]
Blum, A.S., Dal Pan, G.J., Feinberg, J., Raines, C., Mayjo, K., Cornblath, D. R., McArthur, J.C.
(1996). Low-dose zalcitabine-related toxic neuropathy: Frequency, natural history, and risk factors.. Neurology
46: 999-1003
[Abstract][Full Text]
Wald, A., Zeh, J., Selke, S., Ashley, R. L., Corey, L.
(1995). Virologic Characteristics of Subclinical and Symptomatic Genital Herpes Infections. NEJM
333: 770-775
[Abstract][Full Text]
Lossos, A., River, Y., Eliakim, A., Steiner, I.
(1995). Neurologic Aspects of Inflammatory Bowel Disease. Neurology
45: 416-421
[Abstract][Full Text]
Cowan, F M, Johnson, A M, Ashley, R, Corey, L, Mindel, A
(1994). Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ
309: 1325-1329
[Abstract][Full Text]
Celum, C. L., Coombs, R. W., Jones, M., Murphy, V., Fisher, L., Grant, C., Corey, L., Inui, T., Wener, M. H., Holmes, K. K.
(1994). Risk Factors for Repeatedly Reactive HIV-1 EIA and Indeterminate Western Blots: A Population-Based Case-Control Study. Arch Intern Med
154: 1129-1137
[Abstract]
Swanson, J. M., Chenitz, W. C.
(1993). Regaining a Valued Self: The Process of Adaptation to Living with Genital Herpes. Qual Health Res
3: 270-297
[Abstract]
Siegel, D., Golden, E., Washington, A. E., Morse, S. A., Fullilove, M. T., Catania, J. A., Marin, B., Hulley, S. B.
(1992). Prevalence and Correlates of Herpes Simplex Infections: The Population-Based AIDS in Multiethnic Neighborhoods Study. JAMA
268: 1702-1708
[Abstract]
Mertz, G. J., Benedetti, J., Ashley, R., Selke, S. A., Corey, L.
(1992). Risk Factors for the Sexual Transmission of Genital Herpes. ANN INTERN MED
116: 197-202
[Abstract]
(1991). Current Trends in Premarital Sexual Experience Among Adolescent Women--United States, 1970-1988. Arch Dermatol
127: 311-312
[Abstract]
Albrecht, L. M., Wilkes, L. C.
(1991). Sexually Transmitted Diseases. Journal of Pharmacy Practice
4: 237-246
(1990). Health Objectives for the Nation Progress Toward Achieving the 1990 Objectives for the Nation for Sexually Transmitted Diseases. Arch Pediatr Adolesc Med
144: 529-530
[Abstract]
(1990). Herpes Gladiatorum at a High School Wrestling Camp-Minnesota. Arch Dermatol
126: 439-439
[Abstract]
(1989). GENITAL HERPES INFECTION IS COMMON. JWatch General
1989: 6-6
[Full Text]
Previous
